These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 20704980)

  • 1. Cell surface growth factor receptor molecules as targets for cancer therapy.
    Fischer OM; Gschwind A; Ullrich AA
    Discov Med; 2004 Jun; 4(22):166-71. PubMed ID: 20704980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physician Education: The Erythropoietin Receptor and Signal Transduction.
    Yoshimura A; Arai K
    Oncologist; 1996; 1(5):337-339. PubMed ID: 10388012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tyrosine kinase receptors as attractive targets of cancer therapy.
    Bennasroune A; Gardin A; Aunis D; Crémel G; Hubert P
    Crit Rev Oncol Hematol; 2004 Apr; 50(1):23-38. PubMed ID: 15094157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The signal transduction of receptor tyrosine kinase].
    Takada T; Matozaki T; Kasuga M
    Nihon Rinsho; 1998 Jul; 56(7):1756-62. PubMed ID: 9702050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative mass spectrometry to investigate epidermal growth factor receptor phosphorylation dynamics.
    Schuchardt S; Borlak J
    Mass Spectrom Rev; 2008; 27(1):51-65. PubMed ID: 18023079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibiton of RET and JAK2 signals and upregulation of VEGFR3 phosphorylation in vitro by galectin-1 in trophoblast tumor cells BeWo.
    Fischer I; Schulze S; Kuhn C; Friese K; Walzel H; Markert UR; Jeschke U
    Placenta; 2009 Dec; 30(12):1078-82. PubMed ID: 19900702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Autocrine stimulation of receptor-tyrosine kinases (RTK) in human tumor cell lines in vitro: therapeutic implications].
    Gaumann A; Groot M; Drexler HC; Breier G
    Verh Dtsch Ges Pathol; 2003; 87():232-9. PubMed ID: 16888917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EDG-1 links the PDGF receptor to Src and focal adhesion kinase activation leading to lamellipodia formation and cell migration.
    Rosenfeldt HM; Hobson JP; Maceyka M; Olivera A; Nava VE; Milstien S; Spiegel S
    FASEB J; 2001 Dec; 15(14):2649-59. PubMed ID: 11726541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Receptor tyrosine kinase inhibitors.
    Haluska P; Adjei AA
    Curr Opin Investig Drugs; 2001 Feb; 2(2):280-6. PubMed ID: 11816845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Promoting neurotrophic effects by GPCR ligands.
    Jeanneteau F; Chao MV
    Novartis Found Symp; 2006; 276():181-9; discussion 189-92, 233-7, 275-81. PubMed ID: 16805430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Receptor tyrosine kinase signaling: a view from quantitative proteomics.
    Dengjel J; Kratchmarova I; Blagoev B
    Mol Biosyst; 2009 Oct; 5(10):1112-21. PubMed ID: 19756300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breakdown of endocytosis in the oncogenic activation of receptor tyrosine kinases.
    Abella JV; Park M
    Am J Physiol Endocrinol Metab; 2009 May; 296(5):E973-84. PubMed ID: 19240253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Signal transduction inhibitor].
    Ueda Y; Saijo N
    Gan To Kagaku Ryoho; 2001 May; 28(5):591-600. PubMed ID: 11383206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tyrosine phosphorylation profiling reveals the signaling network characteristics of Basal breast cancer cells.
    Hochgräfe F; Zhang L; O'Toole SA; Browne BC; Pinese M; Porta Cubas A; Lehrbach GM; Croucher DR; Rickwood D; Boulghourjian A; Shearer R; Nair R; Swarbrick A; Faratian D; Mullen P; Harrison DJ; Biankin AV; Sutherland RL; Raftery MJ; Daly RJ
    Cancer Res; 2010 Nov; 70(22):9391-401. PubMed ID: 20861192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Receptor association and tyrosine phosphorylation of S6 kinases.
    Rebholz H; Panasyuk G; Fenton T; Nemazanyy I; Valovka T; Flajolet M; Ronnstrand L; Stephens L; West A; Gout IT
    FEBS J; 2006 May; 273(9):2023-36. PubMed ID: 16640565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Signal transduction in cell-matrix interactions.
    Guan JL; Chen HC
    Int Rev Cytol; 1996; 168():81-121. PubMed ID: 8843649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vesicular trafficking of tyrosine kinase receptors and associated proteins in the regulation of signaling and vascular function.
    Mukherjee S; Tessema M; Wandinger-Ness A
    Circ Res; 2006 Mar; 98(6):743-56. PubMed ID: 16574915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Receptor tyrosine kinases and the regulation of hematopoiesis.
    Paulson RF; Bernstein A
    Semin Immunol; 1995 Aug; 7(4):267-77. PubMed ID: 8520031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New paradigms in anticancer therapy: targeting multiple signaling pathways with kinase inhibitors.
    Faivre S; Djelloul S; Raymond E
    Semin Oncol; 2006 Aug; 33(4):407-20. PubMed ID: 16890796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of receptor tyrosine kinase-based signal transduction as specific target for cancer treatment.
    Roussidis AE; Karamanos NK
    In Vivo; 2002; 16(6):459-69. PubMed ID: 12494890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.